New York State Common Retirement Fund’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Hold |
19,719
| – | – | ﹤0.01% | 2125 |
|
|
2025
Q1 | $266K | Hold |
19,719
| – | – | ﹤0.01% | 2114 |
|
|
2024
Q4 | $378K | Hold |
19,719
| – | – | ﹤0.01% | 2038 |
|
|
2024
Q3 | $449K | Hold |
19,719
| – | – | ﹤0.01% | 1976 |
|
|
2024
Q2 | $257K | Buy |
19,719
+1,773
| +10% | +$23.1K | ﹤0.01% | 2319 |
|
|
2024
Q1 | $314K | Buy |
17,946
+451
| +3% | +$7.89K | ﹤0.01% | 2264 |
|
|
2023
Q4 | $378K | Buy |
17,495
+1,545
| +10% | +$33.4K | ﹤0.01% | 2212 |
|
|
2023
Q3 | $236K | Buy |
15,950
+155
| +1% | +$2.29K | ﹤0.01% | 2354 |
|
|
2023
Q2 | $376K | Sell |
15,795
-4,133
| -21% | -$98.4K | ﹤0.01% | 2215 |
|
|
2023
Q1 | $513K | Sell |
19,928
-2,892
| -13% | -$74.4K | ﹤0.01% | 2163 |
|
|
2022
Q4 | $666K | Buy |
22,820
+4,804
| +27% | +$140K | ﹤0.01% | 2175 |
|
|
2022
Q3 | $363K | Buy |
18,016
+216
| +1% | +$4.35K | ﹤0.01% | 2497 |
|
|
2022
Q2 | $206K | Buy |
+17,800
| New | +$206K | ﹤0.01% | 2793 |
|
|
2019
Q2 | – | Sell |
-1,893
| Closed | -$79K | – | 3296 |
|
|
2019
Q1 | $79K | Hold |
1,893
| – | – | ﹤0.01% | 3007 |
|
|
2018
Q4 | $86K | Hold |
1,893
| – | – | ﹤0.01% | 2993 |
|
|
2018
Q3 | $158K | Hold |
1,893
| – | – | ﹤0.01% | 2929 |
|
|
2018
Q2 | $182K | Buy |
1,893
+993
| +110% | +$95.5K | ﹤0.01% | 2910 |
|
|
2018
Q1 | $95K | Hold |
900
| – | – | ﹤0.01% | 2965 |
|
|
2017
Q4 | $141K | Hold |
900
| – | – | ﹤0.01% | 2895 |
|
|
2017
Q3 | $124K | Hold |
900
| – | – | ﹤0.01% | 2957 |
|
|
2017
Q2 | $175K | Buy |
+900
| New | +$175K | ﹤0.01% | 2908 |
|